New stainless steel access interlock prevents accidental lock-in in dangerous areas

Published: 16-Apr-2010
Manufacturing Regulatory

SERV Trayvou Interverrouillage (STI) has launched the NXO1LTC, a new access interlock with personnel key for harsh or corrosive environments

SERV Trayvou Interverrouillage (STI) has launched the NXO1LTC, a new access interlock with personnel key for harsh or corrosive environments. It consists of a lock with two key slots that work on a free key/trapped key basis.

To gain access to a dangerous area, the operator has to first insert an isolation key into the lock portion. Turning this key releases the personnel key, and allows the bolt to be removed and the door opened.

The operator retains the personnel key while inside the dangerous area. This prevents the door being shut behind them and also stops the machine from being restarted by another person.

The NXO1LTC’s completely stainless steel construction makes it suitable for use in harsh or corrosive environments as the paper, food, robotic, chemical and petrochemical industries.

As an entirely mechanical proposition, the NXO1LTC removes the need for cabling, reducing related maintenance costs and eliminating the risk of a cable malfunction.

STI’s safety products are heavy-duty and comply with all European machinery directives currently in force. They are popular with customers due to their strength and simple method of operation.
See more

You may also like

Manufacturing

Viatris to cut 10% of its global workforce after Indian plant fire

Read more
Viatris has lowered its profit outlook for 2026 after a fire in February shut down a key plant in Nashik, India. Despite this, the company reported stronger-than-expected revenue and announced a restructuring plan

Trending Articles

  1. AFYREN obtains FSSC 22000 certification for industrial site The AFYREN NEOXY plant is now certified for the production and processing of biobased monocarboxylic acids and their derivatives for the food and feed industries, a guarantee of trust and performance for customers
  2. NICE approves Opzelura cream as first UK treatment for non-segmental vitiligo Incyte Biosciences UK has secured NICE approval for Opzelura (ruxolitinib) cream, granting eligible NHS patients with non-segmental vitiligo access to the first and only approved therapy in England shown to support facial re-pigmentation
  3. Top 10 tips for optimal rotary evaporation with Vacuubrand Labtex shares: "In the UK, we supply a comprehensive range of high-quality laboratory and instrumentation vacuum pumps from our trusted partners at Vacuubrand - world leaders in vacuum technology!"
  4. CDA-AMC rejects Leqembi reimbursement despite Health Canada approval After expressing disappointment about a separate insomnia ruling, Eisai has criticised a draft decision by Canada's drug agency not to recommend public reimbursement of Leqembi for early Alzheimer's disease
  5. Johnson & Johnson files FDA application for IMAAVY in wAIHA Johnson & Johnson has submitted an sBLA to the US Food and Drug Administration seeking approval of IMAAVY as the first-ever treatment for warm autoimmune haemolytic anaemia, supported by Phase II/III ENERGY trial data showing rapid and durable haemoglobin response

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

Manufacturing

Viatris to cut 10% of its global workforce after Indian plant fire

Viatris has lowered its profit outlook for 2026 after a fire in February shut down a key plant in Nashik, India. Despite this, the company reported stronger-than-expected revenue and announced a restructuring plan
Regulatory

CStone's sugemalimab approved by MHRA for Stage III NSCLC

The MHRA's decision marks the biopharma's second indication approved for the product in the UK, with a global commercial rollout for sugemalimab now actively underway
Manufacturing

GEA opens new technology centre in Germany

The opening of the new technology centre for pharmaceutical freeze-drying systems will strengthen the supplier's position in the growing pharmaceutical applications market
Regulatory

American Chemistry Council's statement to Trump: make chemistry in America again

The Council has released a statement ahead of the President's State of the Union Address, asking for policies that unlock domestic production and address unfair foreign practices
Regulatory

Johnson & Johnson files FDA application for IMAAVY in wAIHA

Johnson & Johnson has submitted an sBLA to the US Food and Drug Administration seeking approval of IMAAVY as the first-ever treatment for warm autoimmune haemolytic anaemia, supported by Phase II/III ENERGY trial data showing rapid and durable haemoglobin response
Manufacturing

Avoiding product degradation with a low-temperature, vacuum cake dryer

High-performance chemicals often lose efficacy when exposed to heat. Active pharmaceutical ingredients (APIs), fine chemical intermediates, and biologically derived materials are subject to product degradation and can transform, or lose potency under high drying temperatures. This thermal sensitivity demands precise control to maintain molecular stability and ensure product quality
Manufacturing

Cutting-edge customer projects - Specialised systems for multiple sectors

As specialists in laboratory and process chemistry equipment solutions, Labtex have expertise in designing, manufacturing, and installing customised systems for a diverse range industries and disciplines – including chemical manufacturing, drug development, and metals recovery
Subscribe now